1. Sandler AB. Chemotherapy for small cell lung cancer. Semin Oncol. 2003;30:9–25.
2. Noro R, Yoshimura A, Yamamoto K, Miyanaga A, Mizutani H, Minegishi Y, et al. East Japan Chesters Group. Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer. Anticancer Res. 2013;33:1117–23.
3. Wakuda K, Kenmotsu H, Naito T, Akamatsu H, Ono A, Shukuya T, et al. Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer. Am J Clin Oncol. 2015;38:28–32.
4. Yoshida T, Yoh K, Goto K, Niho S, Umemura S, Ohmatsu H, et al. Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease. Anticancer Res. 2013;33:1175–9.
5. Zhou R. The Eph family receptors and ligands. Pharmacol Ther. 1998;77:151–81.